Article Versions Notes

Hirao A, Sato Y, Tanaka H, Nishida K, Tomonari T, Hirata M, Bando M, Kida Y, Tanaka T, Kawaguchi T, et al. MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Cancers. 2021; 13(19):4917. https://doi.org/10.3390/cancers13194917

Hirao, Akihiro, Yasushi Sato, Hironori Tanaka, Kensei Nishida, Tetsu Tomonari, Misato Hirata, Masahiro Bando, Yoshifumi Kida, Takahiro Tanaka, Tomoyuki Kawaguchi, and et al. 2021. "MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma" Cancers 13, no. 19: 4917. https://doi.org/10.3390/cancers13194917

Hirao, A., Sato, Y., Tanaka, H., Nishida, K., Tomonari, T., Hirata, M., Bando, M., Kida, Y., Tanaka, T., Kawaguchi, T., Wada, H., Taniguchi, T., Okamoto, K., Miyamoto, H., Muguruma, N., Tanahashi, T., & Takayama, T. (2021). MiR-125b-5p Is Involved in Sorafenib Resistance through Ataxin-1-Mediated Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Cancers, 13(19), 4917. https://doi.org/10.3390/cancers13194917